A fourteen-rabbit study found reduced tear production and ocular perfusion measures with two sedative combinations. Because the regimens differed in more than one component, the effects cannot be assigned to midazolam alone.
Male New Zealand rabbits received dexmedetomidine with ketamine or dexmedetomidine with midazolam. The dexmedetomidine dose also differed between groups. Investigators measured tear production, ocular perfusion pressure, and pupil diameter before and during a short post-administration period.
Both protocols reduced tear production and perfusion measures. Between-group differences in perfusion and pupil measurements occurred, while within-group pupil change was not significant. These are distinct statistical comparisons.
The study did not use a sedation-depth scale, making equal-depth comparisons difficult. Observation lasted only minutes, and ocular perfusion was estimated rather than directly measured through invasive vascular measurements.
Seven animals per group provide limited precision. Species, healthy male selection, device characteristics, and simultaneous dose changes restrict translation to other veterinary patients or humans.
Medication can affect a physiologic examination as well as facilitate it. In a forensic interpretation, document the complete protocol and timing before treating an ocular observation as a baseline finding. This experiment does not validate a human drug-recognition sign or establish a benzodiazepine-specific pupil effect.
Original analysis of the supplied journal article, identified as PMC13240210.